Cytotoxic Effects of Titanium Dioxide Nanoparticles on MCF-7 Cancer Cell Line

Document Type : Research Article

Authors

1 Department of Basic Sciences, Faculty of Veterinary medicine, Ferdowsi University of Mashhad, Iran.

2 Department of Pathobiology, Faculty of Veterinary medicine, Ferdowsi University of Mashhad, Iran.

3 Department of Clinical Sciences, Faculty of Veterinary medicine, Ferdowsi University of Mashhad, Iran.

Abstract

Cancer is a widespread disease of various types worldwide that affects many people. Today, titanium dioxide nanoparticles have substantial therapeutic applications. We investigated how harmful titanium dioxide is to breast cancer cells. MCF-7 cancer cells and HFF cell lines were cultured. The survival of cells exposed to different amounts of titanium dioxide nanoparticles was tested. The examined concentrations were 25, 50, 100, and 200 μg/ml. The survival rate was measured after 48 and 72 hours and IC50 was determined. We found that the highest toxicity occured  while MCF-7 and HFF cells were exposed to 200 μg/ml of titanium dioxide. Apoptosis in MCF-7 and HFF cells emerged as shown with Annexin V-PI staining and flow cytometry. Under a microscope, it was found that titanium dioxide nanoparticles could be harmful in specific amounts. At a dose of 200 μg/ml, after 48 and 72 hours of treatment, MCF-7 and HFF cells were affected. The mitochondrial membrane broke when breast cells were exposed to titanium dioxide nanoparticles. The matrix leaked into the cytoplasm, and the rough endoplasmic reticulum swelled. These observations occurred after 72 hours of treatment with a concentration of 200 µg/ml. Considering the acquired effects, titanium dioxide nanoparticles may be advocated as potential medicinal candidates for pharmaceutical purposes even though further research is required.

Keywords

Main Subjects


1.   Kleinjans J, Janssen Y, Van Agen B, Hageman G, Schreurs J. Genotoxicity of coal fly ash, assessed in vitro in Salmonella typhimurium and human lymphocytes, and in vivo in an occupationally exposed population. Mutat Res Genet Toxicol. 1989; 224(1): 127-34. Doi: 10.1016/0165-1218(89)90011-6.
2.   Hamel P A,Hanley-Hyde J. G1 cyclins and control of the cell division cycle in normal and transformed cells. Cancer Investig. 1997; 15(2): 143-52. Doi: 10.3109/07357909709115767.
3.   American Cancer Society. Global Cancer Facts & Figures. 2 ed. Atlanta: American Cancer Society; 2014.
4.   Goya M. Iranian Annual Cancer Registration Report 2005/2006. Tehran: Center for Disease Control and Prevention, Iranian Ministry of Health and Medical Education; 2007.
5.   Sadjadi A, Nouraie M, Ghorbani A, Ali Mohammadian M,Malekzadeh R. Epidemiology of breast cancer in the Islamic Republic of Iran: first results from a population-based cancer registry. East. Mediterr. Health J. 2009; 15:1426-31.
6.   Qi L, Xu Z,Chen M. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer. 2007; 43(1): 184-93. Doi:10.1016/j.ejca.2006.08.029.
7.   Wang J J, Sanderson B J,Wang H. Cyto-and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res Genet Toxicol Environ Mutagen. 2007; 628(2): 99-106. Doi: 10.1016/j.mrgentox.2006.12.003.
8.  Dhas S P, John S P, Mukherjee A,Chandrasekaran N. Autocatalytic growth of biofunctionalized antibacterial silver nanoparticles. Biotechnol. Appl. Biochem. 2014; 61(3): 322-332. Doi:/10.1002/bab.1161.
9.   García-Contreras R, Argueta-Figueroa L, Mejía-Rubalcava C, Jiménez-Martínez R, Cuevas-Guajardo S, Sanchez-Reyna P A, et al. Perspectives for the use of silver nanoparticles in dental practice. Int. Dent. J. 2011; 61(6): 297-301. Doi:/10.1111/j.1875-595X.2011.00072.x.
10.   Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983; 65(1-2): 55-63. Doi: 10.1016/0022-1759(83)90303-4.
11.   Lazau C, Mocanu L, Miron I, Sfirloaga P, Tanasiea G, Tatua C, et al. Consideration regarding the use of TiO2 doped nanoparticles in medicine. Dig. J. Nanomater. Biostructures 2007; 2(3): 257-63.
12.   Lopez T, Ortiz-Islas E, Guevara P,Gomez E. Catalytic nanomedicine technology: copper complexes loaded on titania nanomaterials as cytotoxic agents of cancer cell. Int J Nanomedicine. 2013; 581-92. Doi:10.2147/IJN.S37118.
13.   Saimon S M, Kanehira K,Taniguchi A. Comparison of cellular uptake and inflammatory response via Toll-like receptor 4 to lipopolysaccharide and titanium dioxide nanoparticles. Int. J. Mol. Sci. 2013; 14:13154-170. Doi: 10.3390/ijms140713154.
14.   Guichard Y, Schmit J, Darne C, Gaté L, Goutet M, Rousset D, et al. Cytotoxicity and genotoxicity of nanosized and microsized titanium dioxide and iron oxide particles in Syrian hamster embryo cells. Ann Occup Hyg. 2012; 56:63144. Doi:10.1093/annhyg/mes006.
15.   Prasad R Y, Wallace K, Daniel K M, Tennant A H, Zucker R M, Strickland J, et al. Effect of treatment media on the agglomeration of titanium dioxide nanoparticles: impact on genotoxicity, cellular interaction, and cell cycle. ACS nano. 2013; 7(3): 1929-42. Doi:10.1021/nn302280n.
16.   Rahman Q, Lohani M, Dopp E, Pemsel H, Jonas L, Weiss D G, et al. Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in Syrian hamster embryo fibroblasts. Environ. Health Perspect. 2002; 110(8): 797-800. Doi: 10.1289/ehp.02110797.
17.   Shukla R K, Kumar A, Gurbani D, Pandey A K, Singh S, Dhawan A, et al. TiO2 nanoparticles induce oxidative DNA damage and apoptosis in human liver cells. Nanotoxicology. 2013; 7(48e60).DOI: 10.3109/17435390.2011.629747.
18.   Shukla R K, Sharma V, Pandey A K, Singh S, Sultana S, Dhawan A, et al. ROS-mediated genotoxicity induced by titanium dioxide nanoparticles in human epidermal cells. Toxicol In Vitro. 2011; 25:231e241.Doi: 10.1016/j.tiv.2010.11.008.
19.   Srivastava R K, Rahman Q, Kashyap M P, Lohani M,Pant A B. Ameliorative effects of dimetylthiourea and N-acetylcysteine on nanoparticles induced cyto-genotoxicity in human lung cancer cells-A549. PLoS One 2011; 6:e25767. DOI: 10.1371/journal.pone.0025767.
 
CAPTCHA Image
Volume 16, Issue 3 - Serial Number 36
This issue XML files are being prepared.
September 2024
Pages 48-55
  • Receive Date: 21 January 2024
  • Revise Date: 17 June 2024
  • Accept Date: 08 July 2024